Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 report. The full report is available at the Company’s website: www.herantis.com.
Herantis Pharma releases 1H 2025 report today
Seeking Alpha / 17 hours ago 3 Views
Comments